학술논문

Shear stress associated with cardiopulmonary bypass induces expression of inflammatory cytokines and necroptosis in monocytes.
Document Type
article
Source
JCI Insight. 6(1)
Subject
Calcium signaling
Cardiology
Cytokines
Inflammation
Surgery
Animals
Animals
Newborn
Calcium Signaling
Cardiopulmonary Bypass
Cytokines
Female
Heart Defects
Congenital
Humans
Infant
Infant
Newborn
Inflammation Mediators
Interleukin-8
Male
Models
Animal
Monocytes
Necroptosis
RNA-Seq
Stress
Mechanical
Sus scrofa
Systemic Inflammatory Response Syndrome
THP-1 Cells
Tumor Necrosis Factor-alpha
Up-Regulation
Language
Abstract
Cardiopulmonary bypass (CPB) is required during most cardiac surgeries. CBP drives systemic inflammation and multiorgan dysfunction that is especially severe in neonatal patients. Limited understanding of molecular mechanisms underlying CPB-associated inflammation presents a significant barrier to improve clinical outcomes. To better understand these clinical issues, we performed mRNA sequencing on total circulating leukocytes from neonatal patients undergoing CPB. Our data identify myeloid cells, particularly monocytes, as the major cell type driving transcriptional responses to CPB. Furthermore, IL-8 and TNF-α were inflammatory cytokines robustly upregulated in leukocytes from both patients and piglets exposed to CPB. To delineate the molecular mechanism, we exposed THP-1 human monocytic cells to CPB-like conditions, including artificial surfaces, high shear stress, and cooling/rewarming. Shear stress was found to drive cytokine upregulation via calcium-dependent signaling pathways. We also observed that a subpopulation of THP-1 cells died via TNF-α-mediated necroptosis, which we hypothesize contributes to post-CPB inflammation. Our study identifies a shear stress-modulated molecular mechanism that drives systemic inflammation in pediatric CPB patients. These are also the first data to our knowledge to demonstrate that shear stress causes necroptosis. Finally, we observe that calcium and TNF-α signaling are potentially novel targets to ameliorate post-CPB inflammation.